Björn Palitzsch

A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopes.

E. Schmitt, H. Kunz, M. Glaffig, 2014, Angewandte Chemie.

Inside Back Cover: Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures (Chem. Eur. J. 16/2017)

Jia Liu, Mengji Lu, E. Schmitt, 2017 .

Glycopeptide-functionalized gold nanoparticles for antibody induction against the tumor associated mucin-1 glycoprotein.

Edgar Schmitt, Roberto Fiammengo, E. Schmitt, 2016, Bioorganic & medicinal chemistry.

A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables the Diagnosis of Human Pancreatic Cancer.

P. Flemming, E. Schmitt, H. Kunz, 2016, Angewandte Chemie.

A fully synthetic glycopeptide antitumor vaccine based on multiple antigen presentation on a hyperbranched polymer.

H. Frey, E. Schmitt, H. Kunz, 2014, Chemistry.

CpG‐Loaded Multifunctional Cationic Nanohydrogel Particles as Self‐Adjuvanting Glycopeptide Antitumor Vaccines

R. Zentel, E. Schmitt, H. Kunz, 2015, Advanced healthcare materials.

Water-soluble polymers coupled with glycopeptide antigens and T-cell epitopes as potential antitumor vaccines.

R. Zentel, E. Schmitt, H. Kunz, 2013, Angewandte Chemie.

Antibody Induction Directed against the Tumor‐Associated MUC4 Glycoprotein

E. Schmitt, H. Kunz, N. Stergiou, 2015, Chembiochem : a European journal of chemical biology.